Manhattan Scientifics, Inc. (MHTX)

OTCMKTS: MHTX · Delayed Price · USD
0.00 (0.00%)
Jul 18, 2024, 4:00 PM EDT - Market open
Market Cap 559.28K
Revenue (ttm) 2,000
Net Income (ttm) -1.13M
Shares Out 559.28M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 255,500
Open 0.0010
Previous Close n/a
Day's Range n/a
52-Week Range 0.0009 - 0.0079
Beta 1.31
Analysts n/a
Price Target n/a
Earnings Date n/a

About MHTX

Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1992
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol MHTX
Full Company Profile

Financial Performance

Financial Statements


Imagion Expands Collaboration with Siemens Healthineers to United States

NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics Inc. (OTC: MHTX), announces that Siemens & Imagion Biosystems (IBX:ASX) collaborate. U.S. Founder MHTX owns 50 million Shares of Imagion Biosystems. F...

1 year ago - Business Wire